In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Biotin Drug Master File in Korea (Biotin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Biotin. The MFDS reviews the Biotin KDMF as part of the drug registration process and uses the information provided in the Biotin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Biotin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Biotin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Biotin suppliers with KDMF on PharmaCompass.